ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

HROW Harrow Inc

18.00
0.06 (0.33%)
Jun 14 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Harrow Inc HROW NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.06 0.33% 18.00 23:00:08
Open Price Low Price High Price Close Price Previous Close
17.80 17.02 18.2075 17.97 17.94
more quote information »

Recent News

Date Time Source Heading
6/06/202407:00BWMelt Pharmaceuticals Announces First Patient Dosed in..
6/05/202406:00BWHarrow Announces 52-Week Data from VEVYE® ESSENCE-2..
5/15/202406:00BWHarrow to Present at Two Investor Conferences in May
5/13/202415:01BWHarrow Announces First Quarter 2024 Financial Results
5/13/202406:00BWHarrow Names Greg DiPasquale as Senior Vice President, Head..
4/25/202406:00BWHarrow Will Release First Quarter 2024 Financial Results..
4/02/202407:16BWMelt Pharmaceuticals Closes $24 Million Series B Preferred..
3/20/202406:15IHMARKETNEWSJPMorgan boosts dividends, Chipotle unveils 50:1 stock..
3/19/202416:45BWHarrow Announces Fourth Quarter and Year-End 2023 Financial..
3/19/202406:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
3/06/202405:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202406:00BWHarrow Will Release Fourth Quarter and Year-End 2023..
2/21/202418:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202418:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202415:15EDGAR2Form 8-K - Current report
2/15/202415:01BWHarrow Licenses Canadian Rights to Apotex for Five Branded..
2/09/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/29/202415:30EDGAR2Form 8-K - Current report
1/29/202414:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/29/202406:00BWHarrow Announces New Appointments to its Board of Directors
1/11/202406:00BWHarrow Announces Availability of VEVYE® (Cyclosporine..
1/09/202409:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/03/202407:00EDGAR2Form 8-K - Current report
1/03/202406:15BWMelt Pharmaceuticals Provides Corporate Update
1/03/202406:00BWHarrow Partners with Leading Healthcare Market Access..
11/29/202306:00BWHarrow Completes Transfer of the TRIESENCE® New Drug..
11/20/202306:00BWHarrow to Present at Two Investor Conferences in November
11/16/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202318:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202315:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202315:34EDGAR2Form 8-K - Current report
11/13/202315:01BWHarrow Announces Third Quarter 2023 Financial Results
11/03/202315:52EDGAR2Form 8-K - Current report
10/30/202307:00BWHarrow Will Release Third Quarter 2023 Financial Results on..
10/24/202306:00BWHarrow Completes Transfer of NDAs and Launches FLAREX®,..
9/29/202315:01EDGAR2Form 8-K - Current report
9/29/202307:00BWHarrow Health, Inc. Changes Corporate Name to Harrow, Inc.
9/26/202307:00BWMelt Pharmaceuticals Announces Exclusive Development and..
9/20/202317:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/15/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/09/202315:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/202315:05EDGAR2Form 8-K - Current report
8/09/202315:01BWHarrow Announces Second Quarter 2023 Financial Results
7/31/202306:00BWHarrow Launches VIGAMOX® in the U.S.
7/26/202308:00BWHarrow to Announce Second Quarter 2023 Financial Results on..
7/21/202315:02EDGAR2Form 8-K - Current report
7/20/202318:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/20/202318:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/19/202316:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]

Your Recent History

Delayed Upgrade Clock